The Latest Ivf Industry Statistics Explained
As of 2018, approximately 2 million cycles of IVF are performed globally each year.
The statistic that approximately 2 million cycles of in vitro fertilization (IVF) are performed globally each year as of 2018 highlights the widespread usage and importance of IVF as a fertility treatment across the world. IVF is a medical procedure used to help individuals and couples overcome infertility by fertilizing an egg with sperm outside the body and then implanting the embryo into the uterus. The fact that 2 million IVF cycles are conducted annually demonstrates the significant demand for assisted reproductive technologies and the increasing acceptance and accessibility of IVF as a solution for those struggling with infertility worldwide. This statistic underscores the global impact of IVF in addressing fertility challenges and reflects the growing willingness of individuals to seek alternative methods to achieve their reproductive goals.
In 2019, fertility clinics and IVF services in America brought in $4.4 billion in revenue.
In 2019, fertility clinics and in vitro fertilization (IVF) services in America generated a total revenue of $4.4 billion. This statistic highlights the significant financial impact of the fertility industry in the United States, reflecting the increasing demand for reproductive assistance services. The revenue generated by fertility clinics and IVF services demonstrates the growing importance of these services in helping individuals and couples achieve their goal of starting or expanding their families. This statistic also underscores the economic significance of the fertility sector and its role in providing specialized medical care to individuals facing challenges with infertility.
As of 2019, there are over 450 fertility clinics in the United States.
The statistic suggests that in 2019, the United States had a substantial number of fertility clinics, exceeding 450 in total. This number indicates a growing demand for fertility services and reflects the increasing prevalence of fertility treatments and assisted reproductive technologies in the country. The presence of numerous fertility clinics across the country signifies the importance and recognition of infertility issues and the efforts to provide accessible and advanced treatment options to individuals and couples seeking to start or expand their families. The statistic also highlights the competitive landscape in the fertility industry, with a wide range of clinics available to meet the diverse needs of patients across the United States.
The global in-vitro fertilization market is expected to grow at a CAGR of 9.8% from 2021 to 2028.
The statistic indicates that the global in-vitro fertilization market is projected to expand significantly with a compound annual growth rate (CAGR) of 9.8% between 2021 and 2028. This growth rate suggests a steady annual increase in market size over the specified time period. The CAGR provides a measure of the average annual growth rate of the market, which offers valuable insights for investors, industry stakeholders, and policymakers in understanding the potential future trends and opportunities in the in-vitro fertilization sector. The consistent growth rate of 9.8% signifies a promising outlook for the industry, driven by factors such as advancements in technology, increasing awareness and acceptance of assisted reproductive technologies, and rising demand for fertility treatments globally.
The global in-vitro fertilization market size was valued at USD 18.3 billion in 2019.
The statistic indicates that the total market size of in-vitro fertilization (IVF) procedures worldwide was estimated at USD 18.3 billion in 2019. This figure represents the combined value of IVF treatment services, technologies, and related products offered by healthcare facilities and providers across various regions globally. The market size reflects the significant demand for assisted reproductive technologies to address infertility issues faced by couples, thereby driving the growth of the IVF industry. Factors such as increasing awareness, advancements in IVF techniques, and changing lifestyle patterns have contributed to the expansion of the global IVF market, making it a key player in the healthcare industry.
On average, a cycle of IVF in the U.S. costs between $10,000 to $15,000.
The statistic that on average, a cycle of in vitro fertilization (IVF) in the United States costs between $10,000 to $15,000 indicates the typical range of expenses that individuals or couples can expect to incur when undergoing this assisted reproductive technology procedure. The costs associated with IVF can vary depending on a variety of factors including the clinic, the specific services needed, any additional treatments required, and the location of the clinic. The average cost range provided serves as a general guideline for those considering IVF treatment and highlights the significant financial investment that may be required for individuals seeking fertility support through this technology in the U.S.
The success rate for IVF treatments in women under 35 is approximately 40%.
The statistic that the success rate for IVF treatments in women under 35 is approximately 40% indicates that around 40 out of 100 women in this age group who undergo in vitro fertilization (IVF) are successful in achieving a live birth. This statistic is important for couples considering IVF as a fertility treatment, as it provides them with an estimate of the likelihood of success based on age. The fact that the success rate is relatively high in women under 35 suggests that they may have a better chance of a successful outcome compared to older women, as fertility generally declines with age. It also highlights the effectiveness of IVF as a treatment option for infertility in younger women.
The average age of women undergoing IVF in the U.S. in 2019 was 35.7 years.
The statistic that the average age of women undergoing in vitro fertilization (IVF) in the United States in 2019 was 35.7 years signifies the typical age of women seeking fertility treatments during that period. This data point suggests that a significant portion of women pursuing IVF are in their mid-thirties, which is a common age range for individuals encountering fertility challenges or delays in starting a family. Understanding the average age of women undergoing IVF can provide insights into trends related to fertility preservation, delayed childbearing, and the preferences of individuals or couples seeking assisted reproductive technologies to achieve pregnancy.
The total number of IVF cycles carried out in Europe in 2014 was close to 700,000.
The statistic that the total number of IVF cycles carried out in Europe in 2014 was close to 700,000 indicates a substantial prevalence and utilization of in vitro fertilization (IVF) procedures within the region during that year. IVF is a widely used assisted reproductive technology for individuals or couples experiencing infertility or other reproductive challenges. The significant number of cycles highlights the importance and acceptance of IVF as a viable option for achieving pregnancy within Europe, showcasing the advancements in medical technology and access to reproductive healthcare services in the continent.
In the U.S., 284,385 assisted reproductive technology procedures were performed in 2017 resulting in the birth of 78,052 babies.
In 2017, a total of 284,385 assisted reproductive technology procedures were conducted in the United States, leading to the birth of 78,052 babies. This statistic highlights the increasing use and success of assisted reproductive technologies in helping individuals and couples achieve their goal of starting or expanding their families. The high number of procedures performed demonstrates the significant reliance on assisted reproductive technologies as a solution to infertility issues faced by many individuals. The successful birth of 78,052 babies showcases the positive impact of these procedures in fulfilling the desire for parenthood and highlights the importance of advancements in reproductive technologies in modern society.
Approximately 1.7% of all infants born in the United States every year are conceived using assisted reproductive technology.
The statistic that approximately 1.7% of all infants born in the United States every year are conceived using assisted reproductive technology (ART) highlights the increasing prevalence and importance of these technologies in modern society. ART encompasses various medical procedures such as in vitro fertilization (IVF) and intrauterine insemination (IUI), which assist individuals or couples struggling with fertility issues to achieve pregnancy. This statistic underscores the significant impact that ART is having on addressing infertility challenges and enabling individuals to experience the joy of parenthood. It also sheds light on the evolving landscape of family-building practices and the role that advanced reproductive technologies play in shaping the demographic trends of the population.
Only around 5% of couples with infertility seek IVF.
The statistic that only around 5% of couples with infertility seek in vitro fertilization (IVF) indicates that the majority of couples facing infertility do not pursue this particular assisted reproductive technology. There could be several reasons for this relatively low utilization rate, including financial constraints, lack of access to IVF services, concerns about the success rates and potential risks associated with the procedure, as well as personal beliefs and preferences regarding fertility treatments. This statistic highlights the need for increased awareness, education, and support for couples navigating infertility challenges, as well as the importance of exploring a range of treatment options tailored to individual circumstances.
The global market value for preimplantation genetic diagnosis (a type of IVF) is expected to reach approximately $121 million by 2023.
Based on current trends and projections, the global market value for preimplantation genetic diagnosis (PGD) is anticipated to grow to around $121 million by the year 2023. This statistic indicates a significant market potential and increased demand for PGD services, which are used in conjunction with in vitro fertilization (IVF) procedures to screen embryos for genetic disorders before implantation. The growth in market value reflects advancements in technology, rising awareness of genetic testing, and the increasing prevalence of couples seeking fertility treatments worldwide. This statistic underscores the importance of PGD in assisting couples in making informed decisions about their reproductive health and highlights the expanding opportunities in the IVF market sector.
Embryo freezing is used in 45% of all assisted reproduction treatment cycles in Europe.
The statistic that embryo freezing is used in 45% of all assisted reproduction treatment cycles in Europe indicates that nearly half of the assisted reproductive procedures in the region involve the freezing of embryos for potential future use. Embryo freezing, also known as cryopreservation, is a common practice in assisted reproduction technology where excess embryos from in vitro fertilization procedures are stored at very low temperatures for later transfer if needed. This statistic suggests that embryo freezing is a widely accepted and utilized technique in the field of assisted reproduction across European countries, providing patients with additional opportunities for successful pregnancies and births.
By 2020, more than 9 million babies were born worldwide thanks to IVF and other advanced fertility treatments.
The statistic indicates that by the year 2020, over 9 million babies globally were born as a result of utilizing in vitro fertilization (IVF) and other advanced fertility treatments. This suggests a significant increase in the number of successful pregnancies achieved through assisted reproductive technologies, highlighting the growing prevalence and success of such treatments in overcoming infertility challenges. The statistic underscores the impact and importance of these medical advancements in helping individuals and couples achieve their goals of having children, while also emphasizing the growing reliance on assisted reproductive techniques in the modern era.
India’s IVF market is predicted to reach $1.45 billion by the year 2026.
This statistic indicates that the in vitro fertilization (IVF) market in India is expected to grow significantly and reach a value of $1.45 billion by the year 2026. This prediction suggests that there is a growing demand for IVF services in India, possibly driven by factors such as increasing infertility rates, greater awareness and acceptance of IVF as a treatment option, advancements in technology and medical practices, as well as improvements in healthcare infrastructure. The projected growth in the IVF market reflects a trend towards more individuals and couples seeking assisted reproductive technologies to overcome infertility issues and fulfill their desire for parenthood.
In the UK, roughly 54,000 patients underwent IVF treatment in 2018.
The statistic “In the UK, roughly 54,000 patients underwent IVF treatment in 2018” indicates that a substantial number of individuals sought assisted reproductive technology to address infertility or other reproductive health issues during that year. In vitro fertilization (IVF) is a complex medical procedure that involves combining an egg and sperm outside the body and then implanting the resulting embryo into the uterus. The fact that 54,000 patients underwent IVF treatment in 2018 highlights both the prevalence of infertility and the increasing willingness of individuals to explore medical solutions for conception challenges. This statistic also underscores the significance of IVF as a key component of reproductive healthcare in the UK.
According to a report, the fertility services market in the U.S. is projected to reach $27.87 billion by 2026.
The statistic indicates that the fertility services market in the United States is expected to grow significantly and reach a value of $27.87 billion by the year 2026. This projection suggests a substantial increase in demand for fertility-related services and treatments in the U.S. over the next few years. Factors contributing to this growth could include advancements in reproductive technologies, an increasing awareness and acceptance of fertility treatments, as well as changes in societal norms related to starting families later in life. This data highlights the importance of the fertility services market within the healthcare industry and the evolving landscape of family planning in the United States.
References
0. – https://www.www.eurekalert.org
1. – https://www.www.hopkinsmedicine.org
2. – https://www.www.cdc.gov
3. – https://www.pubmed.ncbi.nlm.nih.gov
4. – https://www.www.grandviewresearch.com
5. – https://www.www.ibisworld.com
6. – https://www.www.globenewswire.com
7. – https://www.www.eshre.eu
8. – https://www.www.business-standard.com
9. – https://www.www.prnewswire.com
10. – https://www.www.businessinsider.com
11. – https://www.academic.oup.com
12. – https://www.www.hfea.gov.uk
